This was a thoughtful take on the original GeekyAnts article. I especially liked the point about interoperability and model monitoring medical AI can’t be treated like a typical SaaS product where everything ends at deployment. The focus on traceability, data quality, and post-launch monitoring makes the discussion much more practical.
Nick
This was a thoughtful take on the original GeekyAnts article. I especially liked the point about interoperability and model monitoring medical AI can’t be treated like a typical SaaS product where everything ends at deployment. The focus on traceability, data quality, and post-launch monitoring makes the discussion much more practical.